Cowen and Company’s Immunic IMUX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-317,059
| Closed | -$476K | – | 638 |
|
|
2023
Q4 | $476K | Hold |
317,059
| – | – | 0.03% | 180 |
|
|
2023
Q3 | $466K | Sell |
317,059
-40,796
| -11% | -$60K | 0.03% | 173 |
|
|
2023
Q2 | $898K | Hold |
357,855
| – | – | 0.07% | 153 |
|
|
2023
Q1 | $533K | Sell |
357,855
-433,169
| -55% | -$645K | 0.06% | 113 |
|
|
2022
Q4 | $1.11M | Sell |
791,024
-409,667
| -34% | -$574K | 0.12% | 86 |
|
|
2022
Q3 | $3.79M | Hold |
1,200,691
| – | – | 0.36% | 42 |
|
|
2022
Q2 | $4.17M | Sell |
1,200,691
-56,455
| -4% | -$196K | 0.4% | 47 |
|
|
2022
Q1 | $14.2M | Buy |
1,257,146
+1,001,291
| +391% | +$11.3M | 1.37% | 20 |
|
|
2021
Q4 | $2.45M | Buy |
+255,855
| New | +$2.45M | 0.22% | 88 |
|